-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Xinhua News Agency, Hangzhou, April 20 (Reporter Huang Xiao) "In the past, there were more than 20 cases of illness each month.
According to Zhang Jianmin, one of the heads of the brain-computer interface clinical translational research team at Zhejiang University and professor of neurosurgery at the Second Hospital of Zhejiang University, after a month of close follow-up observation, comprehensive analysis of various EEG data and clinical effects, the results are satisfactory.
It is understood that the prevalence of epilepsy in China is about 4.
"It's like installing an'anti-missile system' in the patient's brain, which can monitor the patient's brain electrical activity in real time, and automatically identify the characteristic brain electricity of diseases such as epilepsy, and'alarm' before or immediately after the onset of the disease.
In order to break through the barriers, the brain-computer interface clinical translation research team of Zhejiang University began to explore this field in 2010.
Compared with related foreign products, the closed-loop neurostimulator of the Zhejiang University team uses wireless rechargeable technology to greatly increase the service life of the product, and is smaller in size and lighter in weight.
The patient who underwent the closed-loop neurostimulator implantation operation was a 33-year-old female patient with a history of epilepsy for 19 years.
